Cypress Capital Management (Wyoming)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.9K | Hold |
|
|||||
|
2025
Q1 | $60.2K | Hold |
|
|||||
|
2024
Q4 | $61.4K | Hold |
|
|||||
|
2024
Q3 | $54.8K | Sell |
|
|||||
|
2024
Q2 | $88.2K | Hold |
|
|||||
|
2024
Q1 | $91.3K | Hold |
|
|||||
|
2023
Q4 | $72.8K | Hold |
|
|||||
|
2023
Q3 | $66.2K | Hold |
|
|||||
|
2023
Q2 | $90.1K | Hold |
|
|||||
|
2023
Q1 | $79K | Hold |
|
|||||
|
2022
Q4 | $71.3K | Sell |
|
|||||
|
2022
Q3 | $141K | Hold |
|
|||||
|
2022
Q2 | $162K | Hold |
|
|||||
|
2022
Q1 | $201K | Hold |
|
|||||
|
2021
Q4 | $221K | Sell |
|
|||||
|
2021
Q3 | $422K | Hold |
|
|||||
|
2021
Q2 | $386K | Hold |
|
|||||
|
2021
Q1 | $312K | Sell |
|
|||||
|
2020
Q4 | $3.16M | Sell |
|
|||||
|
2020
Q3 | $5.5M | Sell |
|
|||||
|
2020
Q2 | $4.56M | Sell |
|
|||||
|
2020
Q1 | $4.25M | Sell |
|
|||||
|
2019
Q4 | $5.61M | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.74M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $313K | Buy |
|
|||||
|
2015
Q1 | – | Hold |
|
|||||
|
2014
Q4 | – | Hold |
|